{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:22:34Z","timestamp":1785410554048,"version":"3.56.0"},"reference-count":28,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K07589"],"award-info":[{"award-number":["JP20K07589"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K06699"],"award-info":[{"award-number":["JP23K06699"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H06279 (PAGS)"],"award-info":[{"award-number":["16H06279 (PAGS)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K02240"],"award-info":[{"award-number":["24K02240"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","award":["20 to 25240"],"award-info":[{"award-number":["20 to 25240"]}],"id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007533","name":"Kobayashi Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cell-free DNA (cfDNA) offers a minimally invasive approach to capture genomic and epigenetic dynamics during cancer progression. We performed targeted sequencing of 26 gene loci transcriptionally regulated during the acquisition of therapy resistance in breast cancer and analyzed blood-derived cfDNA from 150 breast cancer samples (105 primary and 45 recurrent). Recurrent samples exhibited increased genomic variant counts in both coding and noncoding regions, accompanied by shorter cfDNA fragment lengths. Furthermore, cfDNA fragmentation profiles were variable in recurrent samples, with frequently amplified loci such as ERBB2 and concurrent reductions at loci, including RERE and SYNPO2. Notably, nucleosome occupancy\u2013derived scores from RERE and SYNPO2 distinguished recurrent from primary cancer with high accuracy (area under the curve = 0.826). Using a machine-learning approach, integration of these cfDNA features accurately predicted breast cancer relapse. Collectively, these findings demonstrate that cfDNA-based profiling focused on transcriptional alterations provides a sensitive strategy for detecting breast cancer recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>cfDNA-based (epi)genomic profiling captures transcriptionally regulated chromatin and nucleosome remodeling during the acquisition of therapy resistance and relapse, enabling minimally invasive, mechanistically informed detection of breast cancer recurrence. Targeting transcriptionally relevant genomic loci provide clinically actionable biomarkers to monitor therapy resistance and guide precision treatment decisions in real time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-26-0263","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:45:12Z","timestamp":1780040712000},"page":"1405-1414","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptionally Informed Nucleosome Profiling of Circulating Cell-Free DNA Predicts Breast Cancer Recurrence"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2120-9546","authenticated-orcid":false,"given":"Sugiko","family":"Watanabe","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02cgss904","id-type":"ROR","asserted-by":"publisher"}],"name":"Kumamoto University 1 Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, , Kumamoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6392-089X","authenticated-orcid":false,"given":"Kan","family":"Etoh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02cgss904","id-type":"ROR","asserted-by":"publisher"}],"name":"Kumamoto University 1 Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, , Kumamoto, Japan."},{"name":"2Department of Molecular Cell Biology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-4765","authenticated-orcid":false,"given":"Jun","family":"Mitsui","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057zh3y96","id-type":"ROR","asserted-by":"publisher"}],"name":"The University of Tokyo 3 Department of Molecular Neurology, Graduate School of Medicine, , Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-9418","authenticated-orcid":false,"given":"Yuta","family":"Suzuki","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/057zh3y96","id-type":"ROR","asserted-by":"publisher"}],"name":"The University of Tokyo 4 Department of Computer Science, Graduate School of Information Science and Technology, , Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-6828","authenticated-orcid":false,"given":"Yutaka","family":"Yamamoto","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02vgs9327","id-type":"ROR","asserted-by":"publisher"}],"name":"Kumamoto University Hospital 5 Department of Breast and Endocrine Surgery, , Kumamoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-8673","authenticated-orcid":false,"given":"Mitsuyoshi","family":"Nakao","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02cgss904","id-type":"ROR","asserted-by":"publisher"}],"name":"Kumamoto University 1 Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, , Kumamoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2026061505285457100_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026061505285457100_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1200\/JCO.2015.65.2289","article-title":"Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Harris","year":"2016","journal-title":"J Clin Oncol"},{"key":"2026061505285457100_bib3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/ng.2822","article-title":"ESR1 ligand-binding domain mutations in hormone-resistant breast cancer","volume":"45","author":"Toy","year":"2013","journal-title":"Nat Genet"},{"key":"2026061505285457100_bib4","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ng.2823","article-title":"Activating ESR1 mutations in hormone-resistant metastatic breast cancer","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"},{"key":"2026061505285457100_bib5","doi-asserted-by":"crossref","first-page":"52142","DOI":"10.18632\/oncotarget.18479","article-title":"Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients","volume":"8","author":"Takeshita","year":"2017","journal-title":"Oncotarget"},{"key":"2026061505285457100_bib6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.trecan.2018.04.005","article-title":"Cancer navigation strategy for endocrine therapy-resistant breast tumors","volume":"4","author":"Nakao","year":"2018","journal-title":"Trends Cancer"},{"key":"2026061505285457100_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41556-020-0514-z","article-title":"Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance","volume":"22","author":"Bi","year":"2020","journal-title":"Nat Cell Biol"},{"key":"2026061505285457100_bib8","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1038\/ncomms7966","article-title":"A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation","volume":"6","author":"Tomita","year":"2015","journal-title":"Nat Commun"},{"key":"2026061505285457100_bib9","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1038\/s41467-019-11378-4","article-title":"The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis","volume":"10","author":"Abdalla","year":"2019","journal-title":"Nat Commun"},{"key":"2026061505285457100_bib10","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell"},{"key":"2026061505285457100_bib11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/cas.12813","article-title":"Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer","volume":"106","author":"Takeshita","year":"2015","journal-title":"Cancer Sci"},{"key":"2026061505285457100_bib12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat Commun"},{"key":"2026061505285457100_bib13","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1038\/s41467-024-54847-1","article-title":"AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients","volume":"15","author":"Knutson","year":"2024","journal-title":"Nat Commun"},{"key":"2026061505285457100_bib14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41467-023-36801-9","article-title":"Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer","volume":"14","author":"Prat","year":"2023","journal-title":"Nat Commun"},{"key":"2026061505285457100_bib15","doi-asserted-by":"crossref","first-page":"104810","DOI":"10.1016\/j.jbc.2023.104810","article-title":"A web-based integrative transcriptome analysis, RNAseqChef, uncovers the cell\/tissue type-dependent action of sulforaphane","volume":"299","author":"Etoh","year":"2023","journal-title":"J Biol Chem"},{"key":"2026061505285457100_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"key":"2026061505285457100_bib17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood.2021012852","article-title":"Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma","volume":"139","author":"Meriranta","year":"2022","journal-title":"Blood"},{"key":"2026061505285457100_bib18","doi-asserted-by":"crossref","first-page":"eaat4921","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci Transl Med"},{"key":"2026061505285457100_bib19","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/1878-0261.13267","article-title":"Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II\u2013IIIA NSCLC patients","volume":"16","author":"Vessies","year":"2022","journal-title":"Mol Oncol"},{"key":"2026061505285457100_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"2026061505285457100_bib21","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1073\/pnas.89.12.5321","article-title":"ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization","volume":"89","author":"Kallioniemi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061505285457100_bib22","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.91.6.2156","article-title":"Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization","volume":"91","author":"Kallioniemi","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061505285457100_bib23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/1078-0432.CCR-21-3017","article-title":"Assessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis","volume":"28","author":"Fitzpatrick","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2026061505285457100_bib24","doi-asserted-by":"crossref","first-page":"e2403871121","DOI":"10.1073\/pnas.2403871121","article-title":"DNA lesion bypass and the stochastic dynamics of transcription-coupled repair","volume":"121","author":"Nicholson","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061505285457100_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.enz.2022.08.003","article-title":"Chromatin organization and DNA damage","volume":"51","author":"Minami","year":"2022","journal-title":"Enzymes"},{"key":"2026061505285457100_bib26","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/s41467-022-35076-w","article-title":"A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA","volume":"13","author":"Doebley","year":"2022","journal-title":"Nat Commun"},{"key":"2026061505285457100_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41587-022-01222-4","article-title":"Inferring gene expression from cell-free DNA fragmentation profiles","volume":"40","author":"Esfahani","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2026061505285457100_bib28","doi-asserted-by":"crossref","first-page":"eadk2082","DOI":"10.1126\/sciadv.adk2082","article-title":"Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions","volume":"10","author":"Hiatt","year":"2024","journal-title":"Sci Adv"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-26-0263\/3799539\/crc-26-0263.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1405\/3803546\/crc-26-0263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1405\/3803546\/crc-26-0263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:29:13Z","timestamp":1781515753000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/6\/1405\/785816\/Transcriptionally-Informed-Nucleosome-Profiling-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-26-0263","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32676266","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676299","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676278","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676275","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676287","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676284","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676263","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676296","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676260","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676293","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676272","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676281","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676290","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676305","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676257","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676302","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32676269","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8537021","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}